Afreen Shariff/X
Feb 26, 2025, 09:07
Afreen Shariff: T minus 2 days to the 2nd ASPIRE and 3rd NICT conference
Afreen Shariff, Associate Director of the Cancer Therapy Toxicity Program at the Center for Cancer Immunotherapy, Duke Cancer InstituteCenter, shared a post on LinkedIn:
“T minus 2 days to the 2nd ASPIRE and 3rd NICT conference.
Looking forward to a rich discussion with representatives regionally, nationally and internationally to discuss the vision for the future, right at the intersection of patient advocacy, irAE management, clinical trials, novel drug development and interventional trials.
Thank you to all our sponsors, speakers and supporters.”
More posts featuring Afreen Shariff.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 17, 2025, 01:33
Aug 16, 2025, 21:51
Aug 16, 2025, 21:38
Aug 16, 2025, 21:05
Aug 16, 2025, 20:40
Aug 16, 2025, 20:29
Aug 16, 2025, 20:27